Triazole compounds that modulate HSP90 activity
US8742133B2 · kind B2 · utility
33Cited by
1References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 13, 2008 |
| Grant date | Jun 3, 2014 |
| Priority date | — |
| Expiry date | Jan 4, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F9/65586
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to substituted triazole compounds and compositions comprising substituted triazole compounds. The invention further relates to methods of inhibiting the activity of Hsp90 in a subject in need thereof and methods for preventing or treating hyperproliferative disorders, such as cancer, in a subject in need thereof comprising administering to the subject a substituted triazole compound of the invention, or a composition comprising such a compound.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.